Dexamethasone enhances trichosanthin-induced apoptosis in the HepG2 hepatoma cell line

Life Sciences

Volumn 86, Issue 1-2, 2010, Pages 10-16

  Li, Meng ^a   Chen, Fei ^a   Liu, Cui Ping ^a   Li, Dong Mei ^a   Li, Xiang ^a   Wang, Chong ^a   Li, Ji Cheng ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Apoptosis; Dexamethasone; HepG2; NF B; Trichosanthin

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; CYCLOOXYGENASE 2; DEXAMETHASONE; I KAPPA B ALPHA; PYRROLIDINE DITHIOCARBAMATE; TRANSCRIPTION FACTOR RELA; TRICHOSANTHIN; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL STRAIN HEPG2; CELL VIABILITY; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG POTENTIATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IC 50; LIVER CELL CARCINOMA; NITROBLUE TETRAZOLIUM TEST; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; LIVER TUMOR; METABOLISM;

ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL SURVIVAL; CYCLOOXYGENASE 2; DEXAMETHASONE; DRUG SYNERGISM; HEP G2 CELLS; HUMANS; I-KAPPA B PROTEINS; LIVER NEOPLASMS; NF-KAPPA B; TRICHOSANTHIN;

EID: 77449088580     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2009.10.016     Document Type: Article

References (52)

1. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270 (5234), 286-290, 1995.
2. Barnes PJ, Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends in Pharmacological Sciences 14 (12), 436-441, 1993.
3. Beg AA, Baldwin Jr AS. The I kappa B proteins: multifunctional regulators of Rel/NFkappa B transcription factors. Genes & Development 7 (11), 2064-2070, 1993.
4. Bentires-Alj M, Barbu V, Fillet M, Chariot A, Relic B, Jacobs N, Gielen J, Merville MP, Bours V. NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene 22 (1), 90-97, 2003.
5. Brown K, Park S, Kanno T, Franzoso G, Siebenlist U. Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. Proceedings of the National Academy of Sciences of the United States of America 90 (6), 2532-2536, 1993.
6. Bui NT, Livolsi A, Peyron JF, Prehn JH. Activation of nuclear factor kappaB and Bcl-x survival gene expression by nerve growth factor requires tyrosine phosphorylation of IkappaBalpha. Journal of Cell Biology 152 (4), 753-764, 2001.
7. Chan WL, Shaw PC, Tam SC, Jacobsen C, Gliemann J, Nielsen MS. Trichosanthin interacts with and enters cells via LDL receptor family members. Biochemical and Biophysical Research Communications 270 (2), 453-457, 2000.
8. Chan WY, Huang H, Tam SC. Receptor-mediated endocytosis of trichosanthin in choriocarcinoma cells. Toxicology 186 (3), 191-203, 2003.
9. Cusack Jr JC, Liu R, Baldwin Jr AS. Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothe cin (CPT-11) in colorectal cancer cells and a xenograft model is overcome by inhibition of nuclear factor-kappaB activation. Cancer Research 60 (9), 2323-2330, 2000.
10. De Bosscher K, Vanden Berghe W, Haegeman G. The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocrine Reviews 24 (4), 488-522, 2003.
11. Dou CM, Li JC. Effect of extracts of Trichosanthes root tubers on HepA-H cells and HeLa cells. World Journal of Gastroenterology 10 (14), 2091-2094, 2004.
12. Evers BM, Thompson EB, Townsend Jr CM, Lawrence JL, Johnson B, Srinivasan G, Thompson JC. Cortivazol increases glucocorticoid receptor expression and inhibits growth of hamster pancreatic cancer (H2T) in vivo. Pancreas 8 (1), 7-14, 1993.
13. Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell 109, S81-S96 Suppl., 2002.
14. Haskill S, Beg AA, Tompkins SM, Morris JS, Yurochko AD, Sampson-Johannes A, Mondal K, Ralph P, Baldwin Jr AS. Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity. Cell 65 (7), 1281-1289, 1991.
15. Hofmann J, Kaiser U, Maasberg M, Havemann K. Glucocorticoid receptors and growth inhibitory effects of dexamethasone in human lung cancer cell lines. European Journal of Cancer 31A (12), 2053-2058, 1995.
16. Huang Y, Johnson KR, Norris JS, Fan W. Nuclear factor-kappaB/IkappaB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells. Cancer Research 60 (16), 4426-4432, 2000.
17. Jin YC. Intra-amniotic injection of crystal trichosanthin for induction of labour in second trimester pregnancy. Sheng Zhi Yu Bi Yun 5 (1), 15-17 20, 1985.
18. Karin M. How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 18 (49), 6867-6874, 1999.
19. Kim YS, Schwabe RF, Qian T, Lemasters JJ, Brenner DA. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells. Hepatology 36 (6), 1498-1508, 2002.
20. Kim SB, Kim JS, Lee JH, Yoon WJ, Lee DS, Ko MS, Kwon BS, Choi DH, Cho HR, Lee BJ, Chung DK, Lee HW, Park JW. NF-kappaB activation is required for cisplatin-induced apoptosis in head and neck squamous carcinoma cells. FEBS Letters 580 (1), 311-318, 2006.
21. Kim DS, Woo ER, Chae SW, Ha KC, Lee GH, Hong ST, Kwon DY, Kim MS, Jung YK, Kim HM, Kim HK, Kim HR, Chae HJ. Plantainoside D protects adriamycin-induced apoptosis in H9c2 cardiac muscle cells via the inhibition of ROS generation and NFkappaB activation. Life Sciences 80 (4), 314-323, 2007.
22. Lau IF, Saksena SK, Chang MC. Further studies on the trichosanthin-induced termination of pregnancy. Contraception 21 (1), 77-86, 1980.
23. Li J, Xia X, Ke Y, Nie H, Smith MA, Zhu X. Trichosanthin induced apoptosis in HL-60 cells via mitochondrial and endoplasmic reticulum stress signaling pathways. Biochimica et Biophysica Acta-General Subjects 1770 (8), 1169-1180, 2007a.
24. Li J, Xia X, Nie H, Smith MA, Zhu X. PKC inhibition is involved in trichosanthin-induced apoptosis in human chronic myeloid leukemia cell line K562. Biochimica et Biophysica Acta-General Subjects 1770 (1), 63-70, 2007b.
25. Liu SF, Ye X, Malik AB. Pyrrolidine dithiocarbamate prevents I-kappaB degradation and reduces microvascular injury induced by lipopolysaccharide in multiple organs. Molecular Pharmacology 55 (4), 658-667, 1999.
26. Lombardi L, Ciana P, Cappellini C, Trecca D, Guerrini L, Migliazza A, Maiolo AT, Neri A. Structural and functional characterization of the promoter regions of the NF(B gene. Nucleic Acids Research 23 (12), 2328-2336, 1995.
27. Mendoza J, Zamora R, Gallardo JC, Ceballos G, Aldana A, Espinosa M, Maldonado V, Melendez-Zajgla J. NF-kappaB does not influence the induction of apoptosis by Ukrain. Cancer Biology & Therapy 5 (7), 788-793, 2006.
28. Olivier S, Robe P, Bours V. Can NF-kappaB be a target for novel and efficient anti-cancer agents? Pharmacology Biochemistry 72 (9), 1054-1068, 2006.
29. Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18 (49), 6853-6866, 1999.
30. Paris R, Morales A, Coll O, Sanchez-Reyes A, Garcia-Ruiz C, Fernandez-Checa JC. Ganglioside GD3 sensitizes human hepatoma cells to cancer therapy. Journal of Biological Chemistry 277 (51), 49870-49876, 2002.
31. Pikarsky E, Ben-Neriah Y. NF-kappaB inhibition: a double-edged sword in cancer? European Journal of Cancer 42 (6), 779-784, 2006.
32. Pineda-Roman M, Zangari M, van Rhee F, Anaissie E, Szymonifka J, Hoering A, Petty N, Crowley J, Shaughnessy J, Epstein J, Barlogie B. VTD combination therapy with bortezomib-thalidomide-dexamethasone is highly effective in advanced and refractory multiple myeloma. Leukemia 22 (7), 1419-1427, 2008.
33. Radhakrishnan SK, Kamalakaran S. Pro-apoptotic role of NF-kappaB: implications for cancer therapy. Biochimica et Biophysica Acta-Reviews on Cancer 1766 (1), 53-62, 2006.
34. Runnebaum IB, Bruning A. Glucocorticoids inhibit cell death in ovarian cancer and upregulate caspase inhibitor cIAP2. Clinical Cancer Research 11 (17), 6325-6332, 2005.
35. Sarkar A, Sreenivasan Y, Ramesh GT, Manna SK. Beta-D-Glucoside suppresses tumor necrosis factor-induced activation of nuclear transcription factor kappaB but potentiates apoptosis. Journal of Biological Chemistry 279 (32), 33768-33781, 2004.
36. Shaw PC, Chan WL, Yeung HW, Ng TB. Minireview: trichosanthin-a protein with multiple pharmacological properties. Life Sciences 55 (4), 253-262, 1994.
37. Shaw PC, Lee KM, Wong KB. Recent advances in trichosanthin, a ribosome-inactivating protein with multiple pharmacological properties. Toxicon 45 (6), 683-689, 2005.
38. Sun J, Wu ZQ, Li Y, Xue Q, Chen J, Chen J, Tang ZQ. Synergistic tumor inhibitory effect of trichosanthin and recombinant interferon α-1b on human liver cancer. Clinical Medical Journal of China 10 (3), 278-280, 2003.
39. Sun J, Wu ZQ, Xue Q, Chen J, Chen J, Tang ZQ. An experimental study on inhibition of lung metastasis of hepatocellular carcinoma by trichosanthin. Chinese Journal of Hepatobiliary Surgery 11 (4), 253-256, 2005.
40. Ten RM, Paya CV, Israel N, Le Bail O, Mattei MG, Virelizier JL, Kourilsky P, Israel A. The characterization of the promoter of the gene encoding the p50 subunit of NF-kappa B indicates that it participates in its own regulation. Embo Journal 11 (1), 195-203, 1992.
41. Venkatraman M, Anto RJ, Nair A, Varghese M, Karunagaran D. Biological and chemical inhibitors of NF-kappaB sensitize SiHa cells to cisplatin-induced apoptosis. Molecular Carcinogenesis 44 (1), 51-59, 2005.
42. Wang Q, Jin S. Trichosanthin, second ed. Science Press, Beijing. Chapter 9, 2000. Wang P, Li JC. Trichosanthin-induced specific changes of cytoskeleton configuration were associated with the decreased expression level of actin and tubulin genes in apoptotic Hela cells. Life Sciences 81 (14), 1130-1140, 2007.
43. Wang CY, Mayo MW, Baldwin Jr AS. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274 (5288), 784-787, 1996.
44. Wang CY, Cusack Jr JC, Liu R, Baldwin Jr AS. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NFkappaB. Nature Medicine 5 (4), 412-417, 1999.
45. Wang P, Yan H, Li JC. CREB-mediated Bcl-2 expression in trichosanthin-induced Hela cell apoptosis. Biochemical Biophysical Research Communications 363 (1), 101-105, 2007.
46. Xia XF, Sui SF. The membrane insertion of trichosanthin is membrane-surface-pH dependent. Biochemical Journal 349 (3), 835-841, 2000.
47. Yamamoto K, Arakawa T, Ueda N, Yamamoto S. Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alphadependent induction of cyclooxygenase-2 in MC3T3-E1 cells. Journal of Biological Chemistry 270 (52), 31315-31320, 1995.
48. Zhang JS, LiuWY. Themechanismof action of trichosanthin oneukaryotic ribosomes-RNA N-glycosidase activity of the cytotoxin. Nucleic Acids Research 20 (6), 1271-1275, 1992.
49. Zhang C, Gong Y, Ma H, An C, Chen D, Chen ZL. Reactive oxygen species involved in trichosanthin-induced apoptosis of human choriocarcinomacells. Biochemical Journal 355 (Pt 3), 653-661, 2001.
50. Zhang S, Lin ZN, Yang CF, Shi X, Ong CN, Shen HM. Suppressed NF-kappaB and sustained JNK activation contribute to the sensitization effect of parthenolide to TNF-alphainduced apoptosis in human cancer cells. Carcinogenesis 25 (11), 2191-2199, 2004.
51. Zhang C, Kolb A, Mattern J, Gassler N, Wenger T, Herzer K, Debatin KM, Buchler M, Friess H, Rittgen W, Edler L, Herr I. Dexamethasone desensitizes hepatocellular and colorectal tumours toward cytotoxic therapy. Cancer Letter 242 (1), 104-111, 2006.
52. Zhang K, Xu J, Huang X, Wu L, Wen C, Hu Y, Su Y, Chen Y, Zhang Z. Trichosanthin downregulated p210Bcr-Abl and enhanced imatinib-induced growth arrest in chronic myelogenous leukemia cell line K562. Cancer Chemotherapy and Pharmacology 60 (4), 581-587, 2007.